- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04066829
Default Dosing Settings for Opioid Prescriptions to Adolescents and Young Adults After Tonsillectomy
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- The University of Michigan
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adolescents and young adults aged 12-25 years undergoing tonsillectomy at C.S. Mott Hospital, University Hospital, Brighton Center for Specialty Care, or Livonia Center for Specialty Care from October 2019-July 2021, excluding April-May 2020 (owing to suspension of elective procedures due to COVID-19).
- Surgeon belongs to the Department of Otolaryngology at the University of Michigan Medical School
- Patients are not any of the following: patients living in foster care or with a legal guardian, patients with medical complexity or developmental delays, non-English speaking patients, patients with recent suicidal ideation documented in their chart, or patients undergoing emergent tonsillectomy.
Exclusion Criteria:
- Patients with prescription opioid use prior to surgery
- Patients undergoing additional procedures at the same time as tonsillectomy (other than minor procedures such as tympanostomy tube placement)
- Patients enrolled in another study
- Patients who are not prescribed opioids post-operatively at discharge
- Patients who are enrolled in the Michigan Pain-control Optimization Pathway (M-POP), which includes education about pain management and a small initial opioid prescription
- Patients with hospitalization with length of stay > 1 day after surgery
- Patients who decline to enroll
- Additional exclusion criteria for secondary analysis: Patients who do not complete the baseline and post-operative day 14 surveys
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental: Default setting intervention
The arm will include all patients undergoing tonsillectomy at C.S. Mott Hospital by a pediatric otolaryngology faculty member at the University of Michigan.
|
The new default settings will be implemented only for patients in the experimental arm.
|
|
No Intervention: No Intervention: Control (Usual Care)
The arm will include all patients undergoing tonsillectomy at University Hospital, Brighton Center for Specialty Care, or Livonia Center for Specialty Care by a general otolaryngology faculty member at the University of Michigan.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Doses in the Initial Discharge Opioid Prescription
Time Frame: Day of discharge, approximately 1 day
|
Doses are defined as the maximum number of instances a patient could take opioids if they took them as prescribed.
Number of doses are calculated from the electronic health record.
|
Day of discharge, approximately 1 day
|
|
Proportion of Patients for Whom the Number of Doses in the Discharge Opioid Prescription Equals the Number of Doses in the New Default Settings
Time Frame: Day of discharge, approximately 1 day
|
The new default settings called for 12 doses in the discharge prescription. This measure assesses the proportion of participants with 12 doses in the discharge prescription, regardless of which arm they were in. Doses are defined as the maximum number of instances a patient could take opioids if they took them as prescribed. Number of doses are calculated from the electronic health record. |
Day of discharge, approximately 1 day
|
|
Proportion of Participants Who Had at Least One Opioid Prescription Refill From University of Michigan During the Two Weeks After Surgery
Time Frame: Day 14
|
Doses are defined as the maximum number of instances a patient could take opioids if they took them as prescribed.
Number of doses are calculated from the electronic health record.
|
Day 14
|
|
Proportion of Patients Who Visited or Saw a University of Michigan Provider Due to Pain During the Two Weeks After Surgery
Time Frame: Day 14
|
Detailed in electronic health record.
Excludes emergency department visits and hospitalizations for pain.
|
Day 14
|
|
Proportion of Patients With at Least One Emergency Department and/or Hospitalization at University of Michigan for Pain During the Two Weeks After Surgery
Time Frame: Day 14
|
Detailed in electronic health record
|
Day 14
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Satisfaction Score on Pain Control During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Participants were surveyed on Day 14 and asked to report level of satisfaction with pain control since their surgery. Pain control satisfaction is on a scale of 1-10 with higher scores indicating higher satisfaction |
Day 14
|
|
Proportion of Patients Who Reported That Their Pain Was Well-controlled as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Day 14
|
|
|
Proportion of Patients Whose Overall Pain Control Was Rated as Much Worse or Worse Than Expected as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Survey was comprised of 5 options:
|
Day 14
|
|
Proportion of Patients Whose Pain Has Resolved by Day 14 After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Survey asked participant on what day pain had resolved.
If participants indicated pain had resolved by Day 14, then they were coded as 1, and 0 otherwise.
|
Day 14
|
|
Pain in the Throat and/or Mouth Over the Past 7 Days at Its Worst as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Pain control is on a scale of 0-10 with higher scores indicating more pain.
|
Day 14
|
|
Pain in the Throat and/or Mouth Over the Past 7 Days on Average as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Pain control is on a scale of 0-10 with higher scores indicating worse pain.
|
Day 14
|
|
Proportion of Patients With Leftover Doses of Opioids as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Participants who answered 'No' to the following question: Did you take all of the opioid pain medications that were prescribed to you during the two weeks after surgery?
|
Day 14
|
|
Number of Opioid Doses Taken During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Patients were asked to report the number of instances in which they used opioids prescribed to them.
|
Day 14
|
|
Proportion of Patients Who Misused Opioids Prescribed to Others at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Includes any use of opioids prescribed to others
|
Day 14
|
|
Proportion of Patients Who Misused Opioids Prescribed to Them at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Includes taking one's own opioids in greater amounts, more often, or longer than directed by a doctor.
|
Day 14
|
|
Patient Health Questionnaire 8-item (PHQ-8) Score (Depression) as Measured by the Post-operative Survey.
Time Frame: Day 14
|
This is an 8-item self-report scale, all items are rated on a score of 0-3, for a total range of 0-24.
Higher scores indicate more depressive symptoms
|
Day 14
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS)- Pediatric Anxiety - Short Form 8a Score as Measured by the Post-operative Survey.
Time Frame: Day 14
|
This measure is 8 items each scored from 1 to 5 points, with the lowest possible raw score being 8 and the highest possible raw score being 40.
Higher scores indicate greater anxiety,
|
Day 14
|
|
Patient-Reported Outcomes Measurement Information System (PROMIS)- Sleep Disturbance - Short Form 4a Score as Measured by the Post-operative Survey.
Time Frame: Day 14
|
This measure is 4 items each scored from 1 to 5 points, with the lowest possible raw score being 8 and the highest possible raw score being 40.
Higher scores indicate greater sleep disturbance, i.e. worse sleep.
|
Day 14
|
|
Proportion of Patients Who Saw Their Primary Care Doctor (or a Colleague) in the Office Due to Pain at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Day 14
|
|
|
Proportion of Patients Who Visited a Retail Clinic Due to Pain at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Day 14
|
|
|
Proportion of Patients Who Visited an Urgent Care Center Due to Pain at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Day 14
|
|
|
Proportion of Patients Who Visited an Emergency Department and/or Were Hospitalized Due to Poorly Controlled Pain at Least Once During the Two Weeks After Surgery as Measured by the Post-operative Survey.
Time Frame: Day 14
|
Day 14
|
|
|
Proportion of Patients With Leftover Doses Who Disposed of Them
Time Frame: 14 Days
|
Proportion of patients with leftover doses who disposed of them
|
14 Days
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Kao-Ping Chua, University of Michigan
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- HUM00159821
- 1K08DA048110 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tonsillectomy
-
Boston Children's HospitalTerminatedPost-tonsillectomy Pain | Post-tonsillectomy Activity | Post-tonsillectomy HydrationUnited States
-
IRCCS Burlo GarofoloRecruiting
-
Fondazione IRCCS Policlinico San Matteo di PaviaRecruiting
-
Medtronic - MITGCompleted
-
University Children's Hospital BaselCompleted
-
Sarah KhanCompleted
-
Wayne State UniversityChildren's Hospital of Michigan FoundationUnknown
-
Centre Hospitalier Universitaire de BesanconCompleted
Clinical Trials on Default setting intervention
-
Lehigh UniversityNational Institute of Mental Health (NIMH)UnknownAttention Deficit Disorder With HyperactivityUnited States
-
Arizona State UniversityCompleted
-
Hadassah Medical OrganizationRecruiting
-
Dana-Farber Cancer InstituteNational Institute of Nursing Research (NINR)RecruitingOvarian Neoplasms | Ovarian Cancer | Ovarian CarcinomaUnited States
-
RenJi HospitalCompleted
-
Corporal Michael J. Crescenz VA Medical CenterCompletedIdiopathic Pulmonary Fibrosis | COPD | Congestive Heart Failure | Malignancy | Severe or Very Severe Airflow Obstruction and/or Receiving or Eligible to Receive Long-term Oxygen Therapy | Other Interstitial Lung Disease Without Curative Therapy | NYHA Class IV or NYHA Class III Plus 1 Hospitalization... and other conditionsUnited States
-
Johns Hopkins Bloomberg School of Public HealthEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompleted
-
University of Colorado, BoulderRecruiting
-
University of MinnesotaCompleted
-
University of WarwickCompletedChronic Disease | Hospital Outpatient ClinicsUnited Kingdom